Clinical Trial

Xuanhuang Runtong Tablet in the Treatment of Constipation (Yin-deficiency Type)

Study acronym: XHRT
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This trial is a randomized, double-blind, placebo-controlled parallel-group, multicenter Phase III clinical trial. It is to evaluate the efficacy and safety of Xuanhuang Runtong Tablets in subjects with constipation (Yin-deficiency type) after 4 weeks of treatment.
Trial Details
NCT Number NCT06740422
Lead Sponsor Beijing Hospital of Traditional Chinese Medicine
Conditions Constipation
Enrollment 300 participants
Start Date 2024-12-15
Primary Completion 2026-12-15 (estimated)
Study Completion 2027-06-15 (estimated)
Updated on ClinicalTrials.gov 2024-12-18